Previous 10 | Next 10 |
Novo Nordisk (NYSE: NVO ) has filed litigation in a Delaware district court against Mylan N.V. (NASDAQ: MYL ) aimed at blocking its attempt to market a generic version of top seller Victoza (liraglutide). The seven patents being challenged expire in 2021 - 2033. More news on: Novo Nordisk ...
Endo International ( ENDP +18.4% ) is up on below-average volume in early trade on the heels of its announcement that subsidiaries Endo Pharmaceuticals, Endo Health Solutions, Par Pharmaceutical and Par Pharmaceutical Companies have agreed in principle to settle lawsuits brought by two c...
Teva Pharmaceutical Industries (NYSE: TEVA ) announces the U.S. commercial launch of its generic version of Mylan's (NASDAQ: MYL ) emergency allergic reaction med EpiPen Jr (epinephrine injection, USP) Auto-Injector, 0.15 mg. More news on: Teva Pharmaceutical Industries Limited, Mylan N....
I've been using a slightly modified version of David Van Knapp's quality scoring system to assess the quality of dividend growth [DG] stocks. My approach has been to grab a list of dividend growth stocks and to determine quality scores for stocks in the list. Additionally, the modifications ...
AbbVie ( ABBV ) announced that it had received FDA approval for updatacitinib to be marketed as RINVOQ. It was approved to treat patients with rheumatoid arthritis. It is estimated that this drug alone for this indication could bring in multi-billion dollars for the company. This is good n...
InsiderInsights' Daily Round-Up articles rate the "Significance" of the Top 10 dollar value insider purchases and sales filed at the SEC on the Title date. Dollar value is only the most basic metric to assess the "Significance" of an insider transaction, however, and often not even the most ...
We have witnessed many innovations in biotechnology, but these innovations were insufficient in the field of contraception. In most cases, we still see only technical improvements to traditional products. Evofem BioSciences (EVFM), with its unique product, brings a novel approach to the trad...
Welcome to The Policy Market - Seeking Alpha's presentation of today’s top policy-related news stories with potential market impact. Follow this account and turn the e-mail alert on to receive this article in your inbox each morning before the market open. Monetary policy in focus as...
Mylan stock has dropped 8.5% today after Mylan (NASDAQ:MYL) was slammed by two prominent US lawmakers. Coordinated Obstruction The company, along with two other major pharmaceuticals, is being investigated as part of an ongoing probe by the US House of Representative’s oversight ...
The FDA approves TB Alliance's pretomanid, as part of a three-drug that includes bedaquiline and linezolid, for the treatment of extensively drug-resistant tuberculosis (TB). More news on: Mylan N.V., Healthcare stocks news, Read more ...
News, Short Squeeze, Breakout and More Instantly...
Mylan Announces Third Quarter 2020 Financial Results and Looks Ahead to the Launch of Viatris Inc. PR Newswire HERTFORDSHIRE, England and PITTSBURGH, Nov. 6, 2020 HERTFORDSHIRE, England and PITTSBURGH , Nov. 6, 2020 /PRNewswire/ -- Mylan N.V. (NASDAQ...
Our experts issued a rare "Double Down" Buy alert on this one stock... Learn more. A long-awaited deal will soon be done. Pfizer (NYSE: PFE) and Mylan (NASDAQ: MYL) announced last week that the U.S. Federal Trade Commission has approved the planned merger of Pfizer's...
Mylan Announces Appointment of Experienced Pharmaceutical Executive Bill Szablewski as Head of Capital Markets for Viatris PR Newswire HERTFORDSHIRE, England, and PITTSBURGH, Nov. 2, 2020 HERTFORDSHIRE , England, and PITTSBURGH, Nov. 2, 2020 /PRNews...